ExoStemTech, founded on March 8, 2016 at Hanyang University ERICA Business Incubation Center, is a biotech company that explores and harnesses beneficial features of exosomes to improve the quality of human life.
EXOSTEMTECH
Category:
Venture
Main Business Area
ExoStemTech’s main pipeline is stem cell-derived exosome therapeutics for various indications including osteoarthritis, liver fibrosis, and lung fibrosis. Especially, Cartisome®, the lead asset to treat osteoarthritis, is about to enter a phase 1 clinical trial as of October 2022.
| Contact Details | 405, ERICC Building, 55, Hanyangdaehak-ro, Sangnok-gu, Ansan-si, Gyeonggi-do +82-31-400-3941contact@exostemtech.com |
|---|
Find out more companies
Related products
-
-
-
VentureMedigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
-